Search results
Doctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ Strains
Prevention via Yahoo News· 18 hours agoNew COVID-19 variants known as “FLiRT,” KP.2 and KP.1.1, are spreading fast in the U.S. Doctors...
COVID-19 kills 2 more in N.B., child and youth hospitalized
CBC via Yahoo News· 13 hours agoCOVID-19 has killed two more New Brunswickers, while a child under four and a youth aged five to 19...
Study reveals how COVID-19 vaccines prevent severe disease
Medical Xpress· 5 days agoResults of this study, published in the journal Nature Communications, categorically show a reduction in indicators of disease severity in those who had received the vaccine
Fact Check: No evidence of mRNA cancer ‘explosion’ in Japan, no national emergency declared
Reuters· 13 hours agoJapan has not declared a national emergency over a purported explosion of cancer cases, a health...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 day agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
MRNA vaccine effective in treating glioblastoma brain cancer in small trial
UPI· 6 days agoThe cancer vaccine is based on mRNA technology similar to that used in COVID-19 vaccines, but in...
FLiRT COVID variants: What are the symptoms?
Newsweek· 10 hours agoScientists are warning of a "summer wave" of COVID-19 cases after a new group of Omicron subvariants was detected circulating in the U.S. The new strains...
Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
Zacks via Yahoo Finance· 7 days agoCencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 2 days agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoDespite financial headwinds, Moderna's robust mRNA technology platform and extensive pipeline of...